Opportunity Information: Apply for RFA RM 18 006

The Limited Competition: Building Infrastructure Leading to Diversity (BUILD) Initiative Phase II (U54, Clinical Trial Not Allowed) funding opportunity, RFA-RM-18-006, is a National Institutes of Health (NIH) cooperative agreement intended specifically for institutions that already hold active BUILD awards. BUILD is one of three connected efforts under the Enhancing the Diversity of the NIH-Funded Workforce Program, also called the Diversity Program Consortium (DPC). The other two parts of the consortium are the National Research Mentoring Network (NRMN) and the Coordination and Evaluation Center (CEC). Together, these initiatives are designed to strengthen and diversify the biomedical research training and career pipeline, with BUILD focusing on campus-based, multi-level change.

This Phase II opportunity is structured to let existing BUILD sites continue and deepen the work they began in Phase I, with an emphasis on both implementation and evaluation. NIH is looking for sites to carry forward a multi-pronged set of interventions that operate at several levels at once: student-facing programming (such as research training experiences and structured academic supports), faculty development (including mentoring capacity and teaching or research enrichment), and broader institutional changes that make biomedical research training environments more inclusive and effective. A central expectation is that applicants will not only run these interventions but also measure what is working, for whom, and under what conditions, so the initiative contributes usable evidence about building a diverse biomedical workforce.

A major theme of this FOA is sustainability. Applicants are expected to lay out a clear plan for transitioning BUILD activities into durable, long-term models that can persist after the award period. In practice, this means NIH is not simply funding short-term programming; it is pushing institutions to embed successful approaches into standard operations, policies, infrastructure, and culture in ways that can be maintained with institutional commitment and diversified funding streams. The sustainability requirement also signals that Phase II should reflect learning from Phase I, including refinements to program design, stronger integration across departments or schools, and clearer pathways for maintaining key components over time.

In addition to sustaining local impact, Phase II applicants are expected to create something that travels. Specifically, each site is expected to develop an effective training, mentoring, or research capacity-building intervention that can be disseminated to other institutions. The goal is broader national impact beyond the original BUILD campuses, meaning the work should produce models, toolkits, curricula, mentoring structures, implementation guides, or other transferable products that other colleges and universities can adopt or adapt. This dissemination focus aligns with NIH interest in scalable practices and reduces the risk that promising approaches remain isolated to a small number of grantee sites.

From an administrative standpoint, this is a discretionary funding opportunity using a cooperative agreement mechanism (U54). The cooperative agreement format generally indicates substantial NIH involvement during the project period compared to a standard research project grant, often through active programmatic collaboration, shared expectations across sites, and coordination with consortium-wide evaluation and learning activities. The FOA is designated "Clinical Trial Not Allowed," which means proposed activities must not meet NIH’s definition of a clinical trial; the work should remain in the realm of training, mentoring, education research, program evaluation, and capacity building rather than interventional clinical research.

Eligibility is limited. The FOA invites applications from the Program Directors/Principal Investigators of current BUILD awards, making this a true limited competition rather than an open call. The listed eligible applicant type includes public and state-controlled institutions of higher education, consistent with the BUILD program’s focus on institutional infrastructure and workforce development. The opportunity explicitly excludes non-U.S. entities and foreign components: non-domestic (non-U.S.) institutions cannot apply, non-domestic components of U.S. organizations are not eligible, and foreign components as defined by the NIH Grants Policy Statement are not permitted. In short, the work and participating components must be entirely domestic within the United States.

Key logistics included in the source data are that the administering agency is NIH, the activity category is Health, and the CFDA number is 93.310. The FOA was created on 2018-04-03, with an original closing date of 2018-06-15. While the provided listing does not specify an award ceiling or the number of expected awards, the intent is clearly continuation and expansion of existing BUILD sites rather than starting new sites, with resources aimed at strengthening proven interventions, improving evaluation, ensuring sustainability, and producing disseminable models that can raise the national impact of the Diversity Program Consortium.

  • The National Institutes of Health in the health sector is offering a public funding opportunity titled "Limited Competition: Building Infrastructure Leading to Diversity (BUILD) Initiative Phase II (U54 Clinical Trial Not Allowed)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.310.
  • This funding opportunity was created on 2018-04-03.
  • Applicants must submit their applications by 2018-06-15. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: Public and State controlled institutions of higher education.
Apply for RFA RM 18 006

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Browse more business programs for Infrastructure Services

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: NINDS Morris K. Udall Center without Walls for Parkinsons Disease Research (P20 Clinical Trial Optional)

Previous opportunity: Outreach and Assistance for Socially Disadvantaged Farmers and Ranchers and Veteran Farmers and Ranchers

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA RM 18 006

 

Applicants also applied for:

Applicants who have applied for this opportunity (RFA RM 18 006) also looked into and applied for these:

Funding Opportunity
Mechanistic Ancillary Studies to Ongoing Clinical Projects (R21 Clinical Trial Not Allowed) Apply for RFA AR 19 007

Funding Number: RFA AR 19 007
Agency: National Institutes of Health
Category: Health
Funding Amount: $250,000
Mechanistic Ancillary Studies to Ongoing Clinical Projects (R01 Clinical Trial Not Allowed) Apply for RFA AR 19 006

Funding Number: RFA AR 19 006
Agency: National Institutes of Health
Category: Health
Funding Amount: $300,000
Impact of Initial Influenza Exposure on Immunity in Infants (U01 Clinical Trial Not Allowed) Apply for RFA AI 18 010

Funding Number: RFA AI 18 010
Agency: National Institutes of Health
Category: Health
Funding Amount: $3,100,000
Making Health care Safer in Ambulatory Care Settings and Long Term Care Facilities (R18) Apply for PA 18 750

Funding Number: PA 18 750
Agency: Agency for Health Care Research and Quality
Category: Health
Funding Amount: Case Dependent
Examining Diversity, Recruitment and Retention in Aging Research (R24 Clinical Trial Not Allowed) Apply for PAR 18 749

Funding Number: PAR 18 749
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Novel Biomarkers for the Development of HIV Incidence Assays with Improved Specificity (R01 Clinical Trial Optional) Apply for PA 18 753

Funding Number: PA 18 753
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Next-Generation Biologics for Sustained HIV Remission (R01 Clinical Trial Not Allowed) Apply for RFA AI 18 017

Funding Number: RFA AI 18 017
Agency: National Institutes of Health
Category: Health
Funding Amount: $500,000
Novel Biomarkers for the Development of HIV Incidence Assays with Improved Specificity (R21 Clinical Trials Not Allowed) Apply for PA 18 754

Funding Number: PA 18 754
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
NIMH Career Transition Award for Tenure-Track Intramural Investigators (K22 No Independent Clinical Trials) Apply for PAR 18 755

Funding Number: PAR 18 755
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Development of Curricular or Training Activities in Skills Development (Admin Supp Clinical Trial Not Allowed) Apply for PA 18 759

Funding Number: PA 18 759
Agency: National Institutes of Health
Category: Health
Funding Amount: $80,000
Development of Curricular or Training Activities in Laboratory Safety (Admin Supp Clinical Trial Not Allowed) Apply for PA 18 758

Funding Number: PA 18 758
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Development of Curricular or Training Activities in Rigor and Transparency to Enhance Reproducibility (Admin Supp Clinical Trial Not Allowed) Apply for PA 18 756

Funding Number: PA 18 756
Agency: National Institutes of Health
Category: Health
Funding Amount: $80,000
Administrative Supplements to NIGMS Predoctoral Training Grants for the Development of Activities to Prepare Trainees for Careers in the Biomedical Research Workforce (Admin Supp Clinical Trial Not Allowed) Apply for PA 18 757

Funding Number: PA 18 757
Agency: National Institutes of Health
Category: Health
Funding Amount: $80,000
Novel Nucleic Acid Sequencing Technology Development (R01 Clinical Trial Not Allowed) Apply for RFA HG 18 001

Funding Number: RFA HG 18 001
Agency: National Institutes of Health
Category: Health
Funding Amount: $700,000
Novel Nucleic Acid Sequencing Technology Development (R43/R44 Clinical Trial Not Allowed) Apply for RFA HG 18 003

Funding Number: RFA HG 18 003
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Novel Nucleic Acid Sequencing Technology Development (R21 Clinical Trial Not Allowed) Apply for RFA HG 18 002

Funding Number: RFA HG 18 002
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
In Vivo Synaptic Function in Alzheimers Disease and Related Dementias (R21 Clinical Trial Not Allowed) Apply for PAR 18 760

Funding Number: PAR 18 760
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed) Apply for PAR 18 761

Funding Number: PAR 18 761
Agency: National Institutes of Health
Category: Health
Funding Amount: $499,000
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems and/or Pharmacodynamic Markers to Facilitate Neurotherapeutic Discovery (R61/R33 Clinical Trial Not Allowed) Apply for PAR 18 763

Funding Number: PAR 18 763
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed) Apply for PAR 18 762

Funding Number: PAR 18 762
Agency: National Institutes of Health
Category: Health
Funding Amount: $499,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA RM 18 006", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: